<DOC>
	<DOC>NCT00065572</DOC>
	<brief_summary>The purpose of this study is to assess the biological activity of ZD6126 in subjects with newly diagnosed metastatic renal cell carcinoma (stage IV).</brief_summary>
	<brief_title>Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Renal Cell</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>Newly diagnosed metastatic renal cell carcinoma Suitable for nephrectomy Prior chemotherapy, biological therapy or radiation therapy for renal cell carcinoma or within the last 3 years for any other cancer Significant cardiac event within 3 months of entry Any history of coronary angioplasty or history of myocardial infarction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Kidney Cancer</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Newly diagnosed renal cell carcinoma</keyword>
</DOC>